Form 4: Ctt Pharmaceutical Holdings Insider Buys Shares
Insider Transaction (Form 4)
Ctt Pharmaceutical Holdings, Inc. reported changes in beneficial ownership of Ctt Pharmaceutical Holdings, Inc. common stock on September 2, 2026.
Summary
- Open-market purchase: acquired 3,000 CTTH at $0.05 ($147) on September 2, 2026; holds 9,387,256 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $147, committing personal capital to the stock.
Insider Transactions
Ctt Pharmaceutical Holdings, Inc. — Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market purchase | CTTH | 3,000 | $0 | $147 | 9,387,256 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market purchase (3,000 shares) |
Keywords
insider transaction, Form 4, CTTH, CTT PHARMACEUTICAL HOLDINGS, INC., bullish, Ctt Pharmaceutical Holdings, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.